Veeva Systems Inc. (0LO3.L)
USD 211.0
(-2.07%)
USD 211.0
(-2.07%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 1.26 Billion USD | 16.36% |
| 2023 | 1.08 Billion USD | 20.25% |
| 2022 | 904.82 Million USD | 16.04% |
| 2021 | 779.74 Million USD | 28.63% |
| 2020 | 606.18 Million USD | 45.71% |
| 2019 | 416.01 Million USD | 26.46% |
| 2018 | 328.96 Million USD | 24.27% |
| 2017 | 264.72 Million USD | 32.0% |
| 2016 | 200.55 Million USD | 45.27% |
| 2015 | 138.05 Million USD | 53.04% |
| 2014 | 90.21 Million USD | 61.51% |
| 2013 | 55.85 Million USD | 104.51% |
| 2012 | 27.31 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q4 | 1.26 Billion USD | 49.66% |
| 2024 Q3 | 845.99 Million USD | -21.34% |
| 2024 Q1 | 1.08 Billion USD | -0.71% |
| 2024 FY | 1.26 Billion USD | 16.36% |
| 2024 Q2 | 1.07 Billion USD | -0.44% |
| 2023 Q2 | 872.65 Million USD | -7.45% |
| 2023 Q3 | 763.92 Million USD | -12.46% |
| 2023 FY | 1.08 Billion USD | 20.25% |
| 2023 Q1 | 942.94 Million USD | 4.21% |
| 2023 Q4 | 1.08 Billion USD | 42.43% |
| 2022 Q2 | 731.28 Million USD | -5.9% |
| 2022 Q1 | 777.16 Million USD | -0.33% |
| 2022 FY | 904.82 Million USD | 16.04% |
| 2022 Q4 | 904.82 Million USD | 51.28% |
| 2022 Q3 | 598.12 Million USD | -18.21% |
| 2021 Q1 | 603.58 Million USD | -0.43% |
| 2021 FY | 779.74 Million USD | 28.63% |
| 2021 Q4 | 779.74 Million USD | 63.38% |
| 2021 Q2 | 559.68 Million USD | -7.27% |
| 2021 Q3 | 477.26 Million USD | -14.73% |
| 2020 Q4 | 606.18 Million USD | 77.31% |
| 2020 Q1 | 441 Million USD | 6.01% |
| 2020 FY | 606.18 Million USD | 45.71% |
| 2020 Q2 | 414.83 Million USD | -5.93% |
| 2020 Q3 | 341.87 Million USD | -17.59% |
| 2019 Q3 | 258.97 Million USD | -17.58% |
| 2019 FY | 416.01 Million USD | 26.46% |
| 2019 Q4 | 416.01 Million USD | 60.64% |
| 2019 Q2 | 314.21 Million USD | -8.45% |
| 2019 Q1 | 343.21 Million USD | 4.33% |
| 2018 Q2 | 269.26 Million USD | -6.1% |
| 2018 Q4 | 328.96 Million USD | 44.44% |
| 2018 Q1 | 286.75 Million USD | 8.32% |
| 2018 FY | 328.96 Million USD | 24.27% |
| 2018 Q3 | 227.74 Million USD | -15.42% |
| 2017 Q2 | 222.12 Million USD | 0.4% |
| 2017 Q4 | 264.72 Million USD | 45.0% |
| 2017 FY | 264.72 Million USD | 32.0% |
| 2017 Q1 | 221.24 Million USD | 10.32% |
| 2017 Q3 | 182.56 Million USD | -17.81% |
| 2016 FY | 200.55 Million USD | 45.27% |
| 2016 Q2 | 137.99 Million USD | -1.23% |
| 2016 Q4 | 200.55 Million USD | 32.77% |
| 2016 Q3 | 151.05 Million USD | 9.46% |
| 2016 Q1 | 139.71 Million USD | 1.2% |
| 2015 FY | 138.05 Million USD | 53.04% |
| 2015 Q4 | 138.05 Million USD | 23.99% |
| 2015 Q3 | 111.34 Million USD | 4.2% |
| 2015 Q2 | 106.85 Million USD | 1.92% |
| 2015 Q1 | 104.83 Million USD | 16.21% |
| 2014 FY | 90.21 Million USD | 61.51% |
| 2014 Q4 | 90.21 Million USD | 20.86% |
| 2014 Q3 | 74.64 Million USD | 14.45% |
| 2014 Q2 | 65.22 Million USD | 5.57% |
| 2014 Q1 | 61.77 Million USD | 10.61% |
| 2013 Q4 | 55.85 Million USD | 0.0% |
| 2013 FY | 55.85 Million USD | 104.51% |
| 2012 FY | 27.31 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Phreesia, Inc. | 119.63 Million USD | -958.29% |
| Accuray Incorporated | 423.54 Million USD | -198.93% |
| Align Technology, Inc. | 2.45 Billion USD | 48.394% |
| Elevance Health Inc. | 69.52 Billion USD | 98.179% |
| AxoGen, Inc. | 101.16 Million USD | -1151.553% |
| Boston Scientific Corporation | 15.6 Billion USD | 91.887% |
| CVS Health Corporation | 173.09 Billion USD | 99.269% |
| Cardinal Health, Inc. | 48.33 Billion USD | 97.38% |
| Centene Corporation | 58.68 Billion USD | 97.843% |
| DaVita Inc. | 14.87 Billion USD | 91.489% |
| HCA Healthcare, Inc. | 55.15 Billion USD | 97.704% |
| Hologic, Inc. | 4.02 Billion USD | 68.552% |
| Humana Inc. | 30.74 Billion USD | 95.882% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | 28.687% |
| Laboratory Corporation of America Holdings | 8.83 Billion USD | 85.669% |
| Masimo Corporation | 1.67 Billion USD | 24.489% |
| McKesson Corporation | 69.04 Billion USD | 98.166% |
| Patterson Companies, Inc. | 1.89 Billion USD | 33.188% |
| Quest Diagnostics Incorporated | 7.6 Billion USD | 83.35% |
| ResMed Inc. | 2 Billion USD | 36.958% |
| Henry Schein, Inc. | 5.42 Billion USD | 76.64% |
| Teladoc Health, Inc. | 2.06 Billion USD | 38.726% |
| Universal Health Services, Inc. | 8.15 Billion USD | 84.474% |
| Baxter International Inc. | 19.8 Billion USD | 93.608% |
| Becton, Dickinson and Company | 26.98 Billion USD | 95.308% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 38.064% |
| Danaher Corporation | 30.99 Billion USD | 95.916% |
| Stryker Corporation | 21.31 Billion USD | 94.061% |
| Medtronic plc | 39.56 Billion USD | 96.8% |